Overview

Pharmacological Management of Delirium

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to develop and test the feasibility of using a specific pharmacological protocol to reduce delirium burden among older adults in the Intensive Care Unit (ICU). The study will test the efficacy of a pharmacological intervention in reducing delirium severity and duration as well as length of stay and mortality compared to usual care.
Phase:
N/A
Details
Lead Sponsor:
Indiana University
Collaborator:
National Institute on Aging (NIA)
Treatments:
Cholinergic Antagonists
Haloperidol
Haloperidol decanoate